Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 351 Results
Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
August 17, 2010
Palatin Technologies, Inc. Announces Last Patient Dosed and Database Lock in Subcutaneous Bremelanotide Trial in Men
June 24, 2010
Palatin Technologies, Inc. Announces Positive Preclinical Data with PL-3994 for Asthma Indications
June 21, 2010
Palatin Technologies, Inc. Issued U.S. Patent and Receives Patent Allowance on Seven Additional Patents
May 4, 2010
Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
February 25, 2010
Page 35 of 36